A pre-ASCO event

For this event, the IQVIA Institute has assembled a multi-stakeholder panel to explore the challenges, key levers, and scenarios for consideration in oncology clinical trial diversity planning processes and in designing and delivering those trials. Our panel will look to address issues such as:

• Determining the 'right' level of diversity to ensure inclusive access and sub-group insights
• Balancing optimal diversity without delaying the availability of new medicines when designing trials and programs
• Adopting varied planning approaches based on trial archetype (e.g., rare vs. non-rare cancer target, level of trial complexity)
• Building effective FDA communication and partnership into diversity planning process
• Implementing clinical trial plans that deliver optimized trial inclusiveness
• Measuring progress across a diverse pipeline of oncology trial archetypes and diversity plans